首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia
Authors:Patrick Rossignol  Nicolas Girerd  George Bakris  Orly Vardeny  Brian Claggett  John J.V. McMurray  Karl Swedberg  Dirk J. van Veldhuisen  Harry Shi  Sean Spanyers  John Vincent  Renaud Fay  Zohra Lamiral  Scott D. Solomon  Faiez Zannad  Bertram Pitt
Affiliation:1. Inserm, Centre d'Investigations Cliniques‐Plurithématique 14‐33, and Inserm U1116, Nancy, France;2. CHU Nancy, P?le de Cardiologie, Vandoeuvre lès Nancy, France;3. Université de Lorraine, France;4. F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France;5. ASH Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, IL, USA;6. University of Wisconsin School of Pharmacy, Madison, WI, USA;7. Brigham and Women's Hospital, Boston, MA, USA;8. The British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK;9. Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;10. University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;11. Pfizer, NY, USA;12. University of Michigan School of Medicine, Ann Arbor, MI, USA
Abstract:
Keywords:Eplerenone  Heart failure  Potassium  Prognosis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号